Hyperphosphatemia rather than hypophosphatemia indicates a poor prognosis in patients with sepsis

Huabin Wang1, Lidan Zhang1, Wenhua Liao2

  • 1Division of Hematology/Oncology, Department of Pediatrics, the Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen 518107, China; Department of Pediatric Intensive Care Unit, the Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen 518107, China.

Clinical Biochemistry
|February 18, 2021
PubMed

Insights

High serum phosphorus (hyperphosphatemia) indicates a poor prognosis in sepsis patients, while low levels do not significantly impact survival. Early identification of high-risk sepsis patients is crucial.

Area of Science:

  • Critical Care Medicine
  • Clinical Chemistry
  • Prognostic Biomarkers

Background:

  • Sepsis is a primary cause of intensive care unit mortality.
  • Identifying high-risk sepsis patients early is essential for improved outcomes.
  • Serum phosphorus levels are investigated as potential prognostic indicators in sepsis.

Purpose of the Study:

  • To evaluate the prognostic significance of serum phosphorus levels in sepsis patients.
  • To determine if hyperphosphatemia or hypophosphatemia predicts mortality in sepsis.

Main Methods:

  • Analysis of 4767 sepsis patients from the MIMIC-III database.
  • Utilized Locally Weighted Scatterplot Smoothing and Kaplan-Meier analysis for initial assessment.
  • Multivariable logistic regression and subgroup analyses were performed to assess in-hospital mortality.

Main Results:

  • Hyperphosphatemia showed a significant correlation with in-hospital mortality (OR 1.48, 95% CI 1.19-1.85).
  • Hypophosphatemia did not demonstrate a significant association with in-hospital mortality (OR 0.91, 95% CI 0.70-1.19).
  • No significant interactions were found between serum phosphorus levels and renal failure, vasopressin use, or SOFA score.

Conclusions:

  • Elevated serum phosphorus (hyperphosphatemia) is a significant indicator of poor prognosis in sepsis.
  • Low serum phosphorus (hypophosphatemia) is not associated with increased mortality in sepsis patients.
Abstract

Related Concept Videos

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
126
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such...
206
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
76
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
201
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
324
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
260